NCT02090816

Brief Summary

The purpose of this study is to determine whether J-shaped thoracophrenolaparotomy is effective in the surgical treatment of simultaneous liver and right lung metastases from colorectal cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
8.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 18, 2014

Completed
Last Updated

March 18, 2014

Status Verified

March 1, 2014

Enrollment Period

8.6 years

First QC Date

February 4, 2014

Last Update Submit

March 14, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of metastases removed

    Evaluation of the resectability of whole metastases in liver and right lung in the same operation by means of the same surgical incision (J-shaped thoracophrenolaparotomy)

    Baseline: date of surgical operation

Secondary Outcomes (2)

  • Number of patients that received interventional treatments after surgery

    Participants will be followed from the baseline (date of surgery) to 90 days after the operation

  • Number of re-operated patients

    Participants will be followed from the baseline (date of surgery) to 90 days after the operation

Study Arms (1)

Surgery of liver and lung

Patients carriers of both liver and right lung metastases in the same time

Procedure: Surgery of liver and lung

Interventions

Simultaneous resection of liver and right lung metastases in a single surgical session through a new approach

Surgery of liver and lung

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Tertiary care clinic

You may qualify if:

  • Controlled primary disease;
  • No extrahepatic lesion other than resectable pulmonary metastases at preoperative investigation;
  • No lymph-node metastases except for those eventually present at the hepatic hilum;
  • Disregarding number and distribution of liver metastases, technical resectability leaving at least a remnant liver volume of at least 40% of the total liver volume (calculated excluding the tumoral volume) featured by preserved inflow, outflow and biliary drainage. Zero mm free margin was considered acceptable in case of contact or close adjacency (\< 5 mm) with 1st or 2nd order portal pedicles and/or major hepatic veins at their caval confluence;
  • Disregarding number and distribution of lung metastases, all of the detected nodules could be completely removed preserving enough functioning remnant lung based on the results of the preoperative cardio-pulmonary functional tests;
  • Patients eligible for a J-shaped thoracophrenolaparotomy because carrier of liver metastases located at the caval confluence, or in the paracaval portion of segment 1 or in the upper right segments (4 superior, 7 and 8), or presenting strong-adhesion or infiltration of the diaphragm.

You may not qualify if:

  • Patients not suitable for surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Clinico Humanitas

Rozzano, Milan, 20084, Italy

Location

MeSH Terms

Conditions

Multiple Pulmonary Nodules

Condition Hierarchy (Ancestors)

Lung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Guido Torzilli, MD PhD FACS

    University of Milan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

February 4, 2014

First Posted

March 18, 2014

Study Start

September 1, 2004

Primary Completion

April 1, 2013

Study Completion

December 1, 2013

Last Updated

March 18, 2014

Record last verified: 2014-03

Locations